Skip to main content
. 2013 Aug 8;8(8):e70533. doi: 10.1371/journal.pone.0070533

Figure 1. Anion-exchange chromatography of low-density lipoprotein (LDL) from a hypercholesterolemic patient.

Figure 1

Chromatograms showing the L5 percentage before treatment (left), after 3 months of atorvastatin treatment (10 mg/day; center), and 3 months after the discontinuation of treatment (right) in hypercholesterolemic patient (baseline plasma LDL-cholesterol level, 226 mg/dL). Treatment with atorvastatin for 3 months reduced the level of L5, and discontinuation of treatment for 3 months resulted in the recurrence of elevated L5.